Ashland Inc. unveils comprehensive excipients business at CPhI 2011
(Thomson Reuters ONE) -
FOR IMMEDIATE RELEASE
Oct. 26, 2011
FRANKFURT, Germany - Ashland Specialty Ingredients, a commercial unit of Ashland
Inc. (NYSE: ASH), is today showcasing its expanded excipient portfolio and
global R&D capabilities that support the formulation development goals of
pharmaceutical companies. At the Convention on Pharmaceutical Ingredients and
Intermediates (CPhI), Ashland is outlining how it plans to support formulators
of pharmaceuticals with expertise in a larger range of formulation approaches
and manufacturing techniques, as well as with a larger portfolio of proven
excipients to address today's drug formulation challenges.
"The former International Specialty Products (ISP) and Ashland Aqualon
Functional Ingredients businesses are now combined as one business - Ashland
Specialty Ingredients - to provide the most comprehensive resources available
from one excipient supplier," said Jeffrey Wolff, group vice president,
Pharmaceutical & Nutrition Specialties, Ashland Specialty Ingredients. "Ashland
now has virtually all of the assets and resources it needs to respond to the
most important drug formulation challenges facing the pharmaceutical industry.
With one of the world's most diversified portfolios of pharmaceutically
acceptable excipients, and an R&D team focused on all of the major formulation
trends, we can help drug makers increase their success on formulation projects."
In outlining Ashland's expanded offerings, Wolff cited some of the most
important formulation priorities of drug makers within the past five years:
* Improving the efficacy of poorly soluble drugs;
* Increasing use of controlled-release technology;
* Orally disintegrating tablet forms for improved patient compliance ; and
* Continuous manufacturing of oral dosage forms.
Wolff said the combination of Ashland and ISP has positioned the company to
better help pharmaceutical formulators address each of these concerns. "With all
of these formulation trends taking place simultaneously, a need exists for a
company such as Ashland to provide a range of excipient solutions," said Wolff.
"A great deal of research taking place at Ashland today will form the basis of
technical solutions that address these formulation and manufacturing trends. We
believe formulators now have a comprehensive source for help in achieving better
outcomes, whatever the formulation challenge."
Ashland Specialty Ingredients offers industry-leading products, technologies and
resources for solving formulation and product performance challenges in key
markets including personal care, pharmaceutical, food and beverage, coatings and
energy. Using natural, synthetic and semi-synthetic polymers derived from plant
and seed extract, cellulose ethers and vinyl pyrrolidones, Ashland Specialty
Ingredients offers comprehensive and innovative solutions for today's demanding
consumer and industrial applications.
In more than 100 countries, the people of Ashland Inc. (NYSE: ASH) provide the
specialty chemicals, technologies and insights to help customers create new and
improved products for today and sustainable solutions for tomorrow. Our
chemistry is at work every day in a wide variety of markets and applications,
including architectural coatings, automotive, construction, energy, food and
beverage, personal care, pharmaceutical, tissue and towel, and water treatment.
Visit www.ashland.com to see the innovations we offer through our four
commercial units - Ashland Specialty Ingredients, Ashland Water Technologies,
Ashland Performance Materials and Ashland Consumer Markets (Valvoline).
- 0 -
FOR FURTHER INFORMATION:
Richard R. Ruberti Sr.
+1 302-594-6850
rruberti(at)ashland.com
Ashland logo:
http://hugin.info/147920/R/1557865/481075.jpg
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Ashland Inc. via Thomson Reuters ONE
[HUG#1557865]
Unternehmensinformation / Kurzprofil:
Datum: 26.10.2011 - 10:05 Uhr
Sprache: Deutsch
News-ID 80278
Anzahl Zeichen: 4777
contact information:
Town:
Covington
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 194 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ashland Inc. unveils comprehensive excipients business at CPhI 2011"
steht unter der journalistisch-redaktionellen Verantwortung von
Ashland Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
